Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Apremilast shows promise for several skin conditions but needs more research.

Consider benefits and risks of new alopecia treatments for safety.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Biologics for severe asthma have known side effects, but some new risks need more study.

Latanoprost eye drops caused excessive cheek hair growth and eyelash whitening in a woman.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Some systemic treatments work for nail psoriasis but can have serious side effects.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

FOXN1 gene variants cause low T cells and immune issues from birth.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Apremilast was not effective in treating moderate-to-severe alopecia areata.